findmyKOL
Clinical trialNCT07126158RecruitingPhase 2Interventional

Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma

SponsorWashington University School of MedicineEnrollment36Cancer of the PancreasPancreas CancerPancreatic AdenocarcinomaPancreatic Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Patrick Grierson, M.D., Ph.D.

    Washington University School of Medicine

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Washington University School of Medicine

    St Louis, Missouri, United States

    Adeel Khan, M.D.Benjamin Tan, M.D.Carl DeSelm, M.D., Ph.D.Dan Mullady, M.D.David DeNardo, Ph.D.Dominic Sanford, M.D.Esther Lu, Ph.D.Gabriel Lang, M.D.Julie Schwarz, M.D., Ph.D.Kian-Huat Lim, M.D., Ph.D.Koushik Das, M.D.Liang I-Kang, M.D., Ph.D.Majella Doyle, M.D.Natasha Leigh-Matijakovich, M.D.Nikolaos Trikalinos, M.D.Olivia Aranha, M.D.Pamela Samson, M.D.Patrick Grierson, M.D., Ph.D.Rama Suresh, M.D.Roheena Panni, M.D., Ph.D.Vladimir Khushnir, M.D.William Chapman, M.D.
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
10 Apr 2026
Primary completion
30 Apr 2030
Completion
30 Apr 2030
Last update posted
15 Apr 2026
Registered enrollment
36
Registry id
NCT07126158

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.